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are considered an organ-sparing alternative to total laryngectomy and chemo-radiotherapy. The main characteristics of SCLs are 
the preservation of the main laryngeal functions as respiration, phonation and swallowing, without a permanent tracheostomy. 
currently accepted, although patient selection criteria and functional results are still debated. The mainstream of this surgery 
is the maintenance of one functioning cricoarytenoid unit to allow restoring of swallowing and phonation. Thus, post-operative 
-
tion protocol improves functional results, in particular regarding swallowing. Swallowing and voice functional outcomes differ 
among several centres and are often related to the post-operative management, although SCLs provide commonly good swal-
lowing and respiratory outcomes. To date, SCLs are proven surgical procedures for the treatment of laryngeal cancer and should 
In this clinical review, we discuss the clinical outcomes in patients treated with SCLs with particular attention to rehabilitation 
protocol and functional outcomes for swallowing and voice rehabilitation. 
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Abbreviations used
CHT – chemotherapy 
ELS – European Laryngological Society 
LSCC – laryngeal squamous cell carcinoma 
MPT – maximum phonation time 
NGT – nasogastric-tube 
OPHL – open partial horizontal laryngectomies
OTT – oral transit time 
PTT – pharyngeal transit time
RT – radiotherapy
RTOG – radiation therapy oncology group
SCLs – supracricoid laryngectomies
TL – total laryngectomy
INTRODUCTION 
Laryngeal squamous cell carcinoma (LSCC) accounts for 
approximately 2% to 5% of all diagnosed cancers, with a 
peak incidence in men between the ages of 55 and 65 (1; 
also see Grasso et al in this volume of Biomedical Reviews). 
The therapeutic strategies developed in the twentieth century 
presenting this cancer; however, post-operatory laryngeal 
dysfunction and a poor prognosis still characterize this pa-
thology in advanced stages (2-4). The proposed treatments 
include surgery alone or in combination with chemotherapy 
(CHT) and radiotherapy (RT) according to cancer location 
and stage at diagnosis. Initial stages (I and II) are treated 
with unimodal treatment which may include surgery and RT, 
while in advanced ones (III and IV) CHT and radical surgery 
are considered the best therapeutic approach (5-9).
Supracricoid laryngectomies (SCLs) are a valuable option 
as an alternative to total laryngectomy (TL) in patient with 
LSCC, since SCLs are considered an organ-sparing surgical 
treatment for selected LSCC in the T2–T4 staging. Surgical 
protocols of organ preservation with SCLs have been ques-
tioned for many years, regarding patient selection criteria and 
functional outcomes (10-13). 
In this clinical review, we discuss the clinical outcomes in 
patients treated with SCLs with particular attention to reha-




SCLs are included by the ELS in the “open partial horizontal 
surgical technique requires resection of the entire thyroid car-
tilage, while the inferior limit is the upper edge of the cricoid 
ring. The differences between the various subtypes of OPHL 
Type II are related to the amount of supraglottis removed and 
their extension to one arytenoid.
OPHL Type II surgical techniques are divided into type 
-
pracricoid laryngectomy with crico-hyoido-epiglottopexy”, 
requires a horizontal incision of the thyro-hyoid membrane 
superiorly, then the pre-epiglottic space and epiglottic cartilage 
are transected so that the suprahyoid part of the epiglottis is 
spared. The inferior constrictor muscles are incised bilater-
ally, the piriform sinuses are dissected, the inferior horns 
of thyroid cartilage are cut, and the ventricular and vocal 
folds are divided down to the lower limit of resection in the 
subglottic region. Larynx reconstruction is achieved by crico-
hyoido-epiglottopexy. OPHL Type IIa can be extended to one 
laryngectomy with crico-hyoidopexy”, requires the resection 
of the thyro-hyoid membrane horizontally along the lower 
border of the hyoid bone. The posterior aspect of the hyoid 
is dissected, and the valleculae and the entire epiglottis are 
included in the surgical specimen. Laterally and inferiorly 
the procedure is carried out as in OPHL Type IIa. The entire 
supraglottis and the pre-epiglottic space are removed. Larynx 
reconstruction is achieved by crico-hyoidopexy. Similarly, 
to Type IIa, OPHL Type IIb can be extended to include one 
arytenoid in the surgical resection.
Rehabilitation protocol 
In patients treated with SCLs, a rehabilitation protocol is es-
sential to allow functional restoring of the “neo-larynx”. The 
rehabilitation protocol is structured in three different phases. 
diaphramatic breathing and pneumophonic coordination exer-
cises are performed with strengthening exercises of preserved 
structures. The second phase takes place from the second to 
fourth postoperative day, and includes pneumophonic coordi-
nation exercises, head and neck mobilization, and protective 
function in compensating posture are performed. In the third 
phase, occurring from the eighth postoperative day, patients 
start swallowing tests with semisolid foods. 
Where practicable, tracheostomy tube should be removed 
between the second and the fourth post-operative day. The 
tracheostomy can be closed when the patient is able to tolerate 
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it without experiencing dyspnea. The nasogastric-tube (NGT) 
can be removed once the function of swallowing solids and 
semi-solids without pulmonary aspiration was regained.
Functional endpoints
The main functional endpoints after SCLs include the swal-
lowing recovery, evaluated by the removal time of the NGT, 
and the respiratory recovery, assessed by the percentage of pa-
tients that achieve tracheostomy decannulation. Evaluation of 
functional results may require in some patients an endoscopic 
oral transit time (OTT) and pharyngeal transit time (PTT). 
The swallowing functional outcome is evaluated by clinical 
or instrumental assessments. The most common clinical as-
sessment reported are the presence and severity of tracheal 
Thus, a standard system for assessing swallowing function 
The evaluation of voice can be achieved with different 
methods, although maximum phonation time (MPT) appears to 
be the most widely used aerodynamic parameter and is meas-
ured on the production of 3 sustained “a”, where the longest 
phonation time was recorded. The GIRBAS scale is one of 
the most widely used scales for perceptual voice evaluation in 
-
eters of voice quality: grade (G), instability (I), roughness (R), 
breathiness (B), asthenia (A), and strain (S); the score ranges 
from 0 (normal voice) to 3 (severe dysphonia).
Self-assessment of patient’s condition may be evaluated 
by several questionnaires to evaluate nutrition, phonation and 
social reintegration. Regarding postoperative swallowing, 
the evaluation of the degree of postoperative suction may be 
archived according to Leipzig (16) and Pearson scales (4) (1 
= none, 2 = occasional cough but no clinical problem, 3 = 
worsening of coughing constantly with meals or swallowing, 
4 = pulmonary complications). The same criteria, still using 
the Leipzig and Pearson scales, have been adopted to evalu-
ate the discourse (1 = good subjective speech, 2 =adequate 
communication, 3 = occasional word or syllable produced, 
4 = reading of the lips necessary to understand the sounds). 
Long-term results should be evaluated at least 6 months after 
surgery, interviewing each patient.
DISCUSSION
Laryngeal cancer treatment has been largely debated as regard-
ing surgical and non-surgical treatment protocols in early-stage 
and in advantage-stage cancer. For initial cancer stages, there 
is a broad consensus that the oncological and functional results 
of transoral laser surgery or RT are equivalent in glottic T1 car-
cinomas (Phase I) and T2 (Phase II), reaching 80% to 95% of 
local control of disease (5, 17, 18). In locally advanced stages, 
the therapeutic choice includes TL, although the problem of 
vocal preservation and airway recovery persuaded surgeons 
to select procedures that spared the organ while guaranteeing 
oncological radicality. Such organ preservation protocols 
necessarily need to evaluate the effects on organ survival and 
function.
Radiotherapy and CHT have been proposed as an alternative 
to TL in locally advanced stages of LSCC in Northern Europe 
and United States. The evaluation of results after RT and CHT 
has been questioned by several studies as the Veteran Affairs 
and RTOG 91-11 (Radiation Therapy Oncology Group 91-11), 
regarding organ preservation and patient survival (5, 7). A se-
vere speech and swallowing impairments are often associated 
oedema with a poorly functioning larynx could be a possible 
reason for negative functional outcomes in organ-preservation 
therapy (19, 20). Moreover, mortality rates for LSCC in the 
1990s and in the 1980s in United Stated showed decreased 
survival rate; this result has been attributed to an increase in 
patients treated with RT/CHT (21).
In several countries of Southern Europe, SCLs have been 
considered an important alternative to TL and RT/CHT for 
LSCC and have been performed for many years since the 
(OPHL Type IIb). SCLs were not habitually performed in 
several Northern European countries as well as in the United 
States, where conservatory RT/CHT treatments have been 
preferred for many years. The explanation of this different 
behavior lies on the post-operative management of SCLs 
that requires a longer hospitalization time and the different 
functional results among centers (23). In the recent years, 
SCLs have gained an increasing agreement around the world 
including the United States.
In our clinical practice SCLs have been performed for 
numerous decades and the best results from an oncologic and 
functional point of view have been obtained with SCL accord-
ing to Labayle and Bismuth (OPHL Type IIb) (24) and SCL 
by various studies, the reconstructive techniques of “OPHL 
Type IIa” and “OPHL Type IIb” are valid in such a way as to 
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equal the TL in terms of survival and oncological radicality (11, 
26, 27). Moreover, the effectiveness of SCLs has been evalu-
ated in residual or recurrent cancer after radiotherapy (28-32). 
Surgical preoperative selection is critical in the achieve-
ment of a successful therapeutic outcome in term of functional 
and oncological results. Thus, surgical feasibility is not the 
most important factor in determining whether SCL is the best 
treatment for an individual patient. Furthermore, the choice 
between SCL and TL must be balanced, considering both 
technical and nontechnical aspects of treatment such as patient 
preferences and mental status. In fact, even when the extension 
of the cancer would allow a SCL, many LSCC patients are 
treated with TL for individual characteristics (26); moreover, 
SCLs can be intraoperatively converted into a OPHL type III 
(Supratracheal laryngectomy) or a TL by the surgeon in order 
to assure a complete excision of the tumor. 
For the early stage of the disease, the extensive use of SCLs 
should be re-considered as there are valid and proven less-inva-
sive surgical and non-surgical alternatives with good functional 
results. In these cases, the use of SCL is only justiciable for cases 
in direct microlaryngoscopy and/or with suspect involvement 
of the prelaryngeal lymph nodes, T2 glottic tumors that involve 
the paraglottic space superiorly and/or inferiorly and that tend 
to behave biologically as authentic T3 cancers (33). 
Given the reported clinical and functional outcomes, SCLs 
can be considered as extremely competitive not only in prog-
nostic terms but also in terms of functional results such as a 
reduction in the number of TL, especially for intermediate 
stages and some advanced stages (T3 and selected T4a) (13). 
The theoretical advantage of SCLs versus TL is the mainte-
nance of the main laryngeal functions (respiration, phonation 
and swallowing) since at least one functioning cricoarytenoid 
unit is maintained facilitating neoglottic competence without a 
permanent tracheotomy (11, 26). Regarding functional results, 
a debate is open as concerning the recovery of swallowing, 
that depends on multiple factors. In fact, a compensatory 
mechanism with the reorganization of the stepwise sequence 
of neuromuscular events is necessary to restore swallowing 
and may require several months (34). Moreover, sphincteric 
approximation of the mobile arytenoid cartilage and base of 
tongue (in the case of OPHL Type IIb), or epiglottis (in the 
case if OPHL Type IIa) provides mucosal source of vibration, 
allowing for voice production (7). 
Post-operative laryngeal oedema prevents arytenoid ad-
duction, resulting in a reduction in laryngeal motility. Oedema 
reduction allows arytenoid motility recovery and greater ef-
fectiveness of neo-glottis closure mechanism. Speech therapy 
rehabilitation allows a progressive recovery of phonation and 
swallowing, improving neoglottic closure, due to the poste-
rior motion of the tongue base (if a OPHL Type IIb has been 
performed) or the epiglottis (if a OPHL Type IIa has been 
performed) and the forward and inward rotation movement of 
one or both remaining arytenoids (34). Thus, a defective glottic 
closure still represents, in patients treated with SCLs, one of the 
most relevant causes of swallowing impairment. 
Several factors may cause a delay in the restoring of swal-
lowing. Woisard et al studied the pharyngeal phase of swal-
lowing in patients treated with OPHL Type IIa, and showed 
defects consisting of a reduced movement of the back of the 
tongue, faulty backward tilting of the epiglottis, reduced 
anterior laryngeal movement and reduced laryngeal eleva-
tion (34). In patient treated with a OPHL Type IIb, a reduced 
movement of the back of the tongue may be also present with a 
reduced posterior motion of the tongue base, a reduced anterior 
laryngeal movement and a reduced laryngeal elevation (34). 
For the above-mentioned conditions, a post-operative 
rehabilitation protocol is essential to archive satisfactory func-
tional outcomes and should be started early to avoid stiffness 
of the arytenoid (35). Early mobilization avoids the onset of 
-
ated with the functional failure of the intervention, requiring 
a TL due to functional incompetence of the neoglottis. The 
purpose of the rehabilitation protocol is the enhancement of 
forced expiration, setting the patient in the most appropriate 
and facilitating compensatory posture, and introducing the 
patient to supraglottic swallowing maneuver.
Compared to a few years ago, rehabilitation techniques 
recommend early decannulation to improve the sensitivity 
arrangement. In fact, the presence of the tracheostomy tube 
may protect against airway aspirations but also limits the 
motility of neolarynx and reduces its sensitivity. Moreover, a 
long permanence of tracheostomy tube is a risk factor for the 
surgery in nearly 30% of cases. In these cases, the closure 
may be problematic for increased subglottic pressure during 
expiration and during cough related to chronic aspiration (36).
Among post-operative complications, laryngotracheal ste-
nosis impacts negatively on postoperative period, requiring a 
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tracheostomy for a longer period and exposing the patient to 
infections and mucosal damage. The use of a Montgomery 
T-tube is a valid strategy in the management of these patients 
(37) often associated with transoral laser surgery/treatment. 
-
tion either by tracheostomy or by stent cannula, with the pos-
sibility to close the outer branch in order to breath and have a 
natural phonation. The main disadvantages are tracheostomy 
Chronic aspiration after SCLs is a very controversial phenom-
enon and may be a cause of failure of this surgery. In a study from 
Simonelli et al., a sample of 164 SCLs patients were evaluated 
for chronic aspiration (38). The degree of postoperative aspira-
tion was evaluated according to Leipzing’s (39) and Pearson’s 
constant cough, worsening during meals. Studies through FEES 
showed that 68% of patients (79 out of 116) had various swal-
lowing alterations and different degrees of aspiration without 
developing aspiration pneumonia. Therefore, some dysphagic 
patients may be able to tolerate certain aspiration degree without 
developing pneumonia suggesting that the action of the ciliary 
A recent review by Schindler (15) regarding functional 
results of SCLs reported a great variability in the mean hos-
pitalization time, feeding-tube removal time and tracheotomy 
tube decannulation time among differ studies (11, 40, 41). 
The mean length of hospital stay varied from a minimum of 5 
days (42) to a maximum of 104 days (41). Mean feeding-tube 
removal time showed similar variability, ranging between 
10 (34) and 88 days (43). Great heterogeneity was found in 
mean decannulation times, varying between 8 days (40) and 
105 days (42). On the contrary, little variability was found 
in decannulation rates, which ranged between 85.7 and 100 
following SCLs.
Concerning phonation recovery, correct and timely logope-
dic therapy is necessary. Reconstructive surgery dramatically 
changes the anatomy of the larynx and the phonation mecha-
nism. Phonation function recovery is almost equivalent in both 
surgical techniques; slightly better voice quality is achieved in 
OPHL Type IIa. SCLs voice is characterized by moderate to 
severe alterations in roughness and grade, slight to moderate 
alterations in breathiness, slight or practically absent altera-
tions in asthenia and slight or moderate alterations in strain 
(15). Assessing voice in SCLs patients with MPT appears to 
be the most widely used aerodynamic parameter. Moreover, 
most authors reported similar data of a highly reduced MPT, 
with values ranging between 8 (11) and 11 seconds (44). 
CONCLUSIONS
Supracricoid laryngectomies allow the maintaining of the 
main laryngeal functions (respiration, phonation and swal-
lowing) since at least one functioning cricoarytenoid unit is 
maintained, without a permanent tracheotomy. These surgical 
techniques have been demonstrated to be proven procedures 
for the treatment of selected laryngeal cancers and should be 
considered as a valuable option to TL and CHT/RT for selected 
patients. Post-operative rehabilitation is essential to achieve 
for functional outcomes and should be started early so as not 
to create stiffness of the arytenoid and avoiding the onset of 
the functional failure. Voice and swallowing functional results 
following SCLs are often satisfactory, although these results 
To date, there is the need to have a consensus and clinical 
recommendations on early post-surgical management, on voice 
and swallowing assessment protocols and on recommended 
timing for rehabilitation. 
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